Philip Day
Philip Day
Verified email at - Homepage
Cited by
Cited by
A gene map of the human genome
GD Schuler, MS Boguski, EA Stewart, LD Stein, G Gyapay, K Rice, ...
Science 274 (5287), 540-546, 1996
A physical map of 30,000 human genes
P Deloukas, GD Schuler, G Gyapay, EM Beasley, C Soderlund, ...
Science 282 (5389), 744-746, 1998
Synthetic biology for the directed evolution of protein biocatalysts: navigating sequence space intelligently
A Currin, N Swainston, PJ Day, DB Kell
Chemical Society Reviews 44 (5), 1172-1239, 2015
Exploring the role of stem cells in cutaneous wound healing
K Lau, R Paus, S Tiede, P Day, A Bayat
Experimental dermatology 18 (11), 921-933, 2009
Miniaturised nucleic acid analysis
PA Auroux, Y Koc, A DeMello, A Manz, PJR Day
Lab on a Chip 4 (6), 534-546, 2004
The need for transparency and good practices in the qPCR literature
SA Bustin, V Benes, J Garson, J Hellemans, J Huggett, M Kubista, ...
Nature methods 10 (11), 1063-1067, 2013
A radiation hybrid map of the rat genome containing 5,255 markers
TK Watanabe, MT Bihoreau, LC McCarthy, SL Kiguwa, H Hishigaki, ...
Nature genetics 22 (1), 27-36, 1999
Total nucleic acid analysis integrated on microfluidic devices
L Chen, A Manz, PJR Day
Lab on a Chip 7 (11), 1413-1423, 2007
Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients
S Sun, MZ Xu, RT Poon, PJ Day, JM Luk
Journal of proteome research 9 (1), 70-78, 2010
Polymerase chain reaction for detection of human cytomegalovirus infection in a blood donor population
IS Bevan, RA Daw, PJR Day, FA Ala, MR Walker
British journal of haematology 78 (1), 94-99, 1991
The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas.
M Weinreb, PJ Day, F Niggli, JE Powell, F Raafat, PB Hesseling, ...
Archives of disease in childhood 74 (1), 27-31, 1996
High-throughput droplet PCR
AL Markey, S Mohr, PJR Day
Methods 50 (4), 277-281, 2010
Quantitative Detection of Streptococcus pneumoniae in Nasopharyngeal Secretions by Real-Time PCR
O Greiner, PJR Day, PP Bosshard, F Imeri, M Altwegg, D Nadal
Journal of clinical microbiology 39 (9), 3129-3134, 2001
Numerical and experimental study of a droplet-based PCR chip
S Mohr, YH Zhang, A MacAskill, PJR Day, RW Barber, NJ Goddard, ...
Microfluidics and Nanofluidics 3, 611-621, 2007
Array-based evolution of DNA aptamers allows modelling of an explicit sequence-fitness landscape
CG Knight, M Platt, W Rowe, DC Wedge, F Khan, PJR Day, A McShea, ...
Nucleic acids research 37 (1), e6-e6, 2009
The consistent association between Epstein-Barr virus and Hodgkin's disease in children in Kenya
M Weinreb, PJ Day, F Niggli, EK Green, AO Nyong'o, NA Othieno-Abinya, ...
2.8‐ crystal structure of a nontoxic type‐II ribosome‐inactivating protein, ebulin l
JM Pascal, PJ Day, AF Monzingo, SR Ernst, JD Robertus, R Iglesias, ...
Proteins: Structure, Function, and Bioinformatics 43 (3), 319-326, 2001
Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles
A Almalik, S Karimi, S Ouasti, R Donno, C Wandrey, PJ Day, N Tirelli
Biomaterials 34 (21), 5369-5380, 2013
Hyaluronic acid-coated chitosan nanoparticles: Molecular weight-dependent effects on morphology and hyaluronic acid presentation
A Almalik, R Donno, CJ Cadman, F Cellesi, PJ Day, N Tirelli
Journal of controlled release 172 (3), 1142-1150, 2013
Dynamics of Epstein‐Barr virus DNA levels in serum during EBV‐associated disease
C Berger, P Day, G Meier, W Zingg, W Bossart, D Nadal
Journal of medical virology 64 (4), 505-512, 2001
The system can't perform the operation now. Try again later.
Articles 1–20